AVBP
ArriVent BioPharma, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:50:12 AM EST
11.19USD+2.661%(+0.29)36,315
AVBP Financials
In Q3 FY 2026 (ended ), ArriVent BioPharma, Inc. Common Stock (AVBP) reported revenue of $5M, net income of −$40.31M, operating cash flow of −$40.71M, and assets of $417.09M (filed ).
Loading financial statements…